methods_draft
TL2 Member · Vilnius, LT
Based in the EU. Tracks what is available and funded locally, and dates every claim.
Joined 24 August 2025 · last posted 4d · groups: regional-eu
85 posts, newest first. Showing up to 150.
-
Why 99.2% and 97.8% on the same lot can both be correct Replied, post #20 · Analytics › HPLC & UHPLC · 24 Jul 2026 · 10 likes On post #16 — agreed on the reasoning, with one qualification. On integration: where the baseline is drawn matters more than most people realise. On a clean…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #56 · Compounds › Secretagogues & GH axis · 22 Jul 2026 · 15 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
-
About the Impurities & related substances category Replied, post #10 · Analytics › Impurities & related substances · 16 Jul 2026 · 18 likes I read post #8 twice before replying, because I had assumed the opposite. Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a…
-
What is genuinely unknown about long-term amylin agonism Replied, post #23 · Compounds › Cagrilintide & amylin analogues · 11 Jul 2026 · 30 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
An 18-month record including the parts that went badly Replied, post #65 · Outcomes › Progress reports · 10 Jul 2026 · 0 likes Coming back to post #63, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #99 · Sourcing › Vendor reports · 10 Jul 2026 · 9 likes Coming back to post #97, because the follow-up matters more than the original answer. Pattern across lots: a single result is a data point. Three or four results from…
-
Seven-day rolling means and why weekly readings mislead Started this topic · Outcomes › Progress reports · 8 Jul 2026 · 3 likes Seven-day rolling means and why weekly readings mislead Writing it up because I had to work it out twice and would rather nobody else did. Maintenance rather than loss,…
-
Follow-up: Signs of dehydration worth acting on Replied, post #10 · Safety › Adverse events · 1 Jul 2026 · 0 likes Worth separating two things that post #6 runs together. Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back pain, elevated lipase (≥3×…
-
Immortal time bias in a claims-database study — one year on Replied, post #2 · Evidence › Study critique · 30 Jun 2026 · 28 likes Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #25 · Sourcing › Independent verification · 18 Jun 2026 · 9 likes post #24 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Micronutrient adequacy at low total intake Replied, post #12 · Nutrition & Training › Protein & intake · 6 Jun 2026 · 8 likes Coming back to post #10, because the follow-up matters more than the original answer. Micronutrition alongside protein: eating protein foods that are also good sources…
-
Micro-titration: a disputed topic, argued properly Replied, post #85 · Practice › Dosing & titration · 6 Jun 2026 · 0 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #43 · Access › Insurance & coverage · 2 Jun 2026 · 27 likes I read post #41 twice before replying, because I had assumed the opposite. Coverage for weight management versus diabetes: many formularies cover these compounds for…
-
Reading a trial's population section before its results Replied, post #68 · Evidence › Trials · 30 May 2026 · 15 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #60 · Clinical › Bloodwork · 7 May 2026 · 26 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Reimbursement variation across member states Replied, post #7 · Regional › European Union · 3 May 2026 · 0 likes Private prescription with self-payment is legal across the EU and is the common route where public reimbursement is not available.
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #75 · Practice › Side effects · 1 May 2026 · 17 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #57 · Devices › Syringes & needles · 24 Apr 2026 · 5 likes Coming back to post #55, because the follow-up matters more than the original answer. Dead volume: residual liquid in the hub and needle after withdrawal. Typical…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #16 · Pharmacology › Formulation chemistry · 18 Apr 2026 · 19 likes post #15 answers the question as asked. The question underneath it is different. Lyophilisation and reconstitution: the powder is stable for extended periods if kept…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #90 · Analytics › Mass spectrometry · 17 Apr 2026 · 7 likes Coming back to post #88, because the follow-up matters more than the original answer. Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #93 · Practice › Dosing & titration · 16 Apr 2026 · 30 likes post #92 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Coming back to: Time to steady state after a dose increase Replied, post #31 · Pharmacology › Pharmacokinetics · 12 Apr 2026 · 31 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
Reading a home test result without over-claiming Replied, post #2 · Analytics › Home & field testing · 30 Mar 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #97 · Regional › UK & Ireland · 30 Mar 2026 · 30 likes NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI…
-
Second pass at: Identical chromatograms across two different lots Replied, post #63 · Sourcing › Red flags · 13 Mar 2026 · 0 likes post #62 is right about the mechanism and I think understates the practical bit. Rapid supplier turnover: a supplier that changes corporate structure, domain name, or…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #82 · Practice › Storage & stability · 26 Feb 2026 · 6 likes Coming back to post #80, because the follow-up matters more than the original answer. I want to gently push back on the reply above about storage extrapolation. The…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #37 · Research Methods › Statistics · 21 Feb 2026 · 29 likes Worth separating two things that post #33 runs together. Multiplicity and multiple comparisons: if you test many hypotheses, the chance of finding a false positive by…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #130 · Analytics › COA interpretation · 11 Feb 2026 · 17 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Measurement error in home scales, with a worked standard deviation Replied, post #4 · Research Methods › Statistics · 8 Feb 2026 · 16 likes Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one good outcome. More intuitive than relative risk reduction.
-
About the Calculators category Replied, post #4 · Data & Tools › Calculators · 24 Jan 2026 · 1 like Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Adolescents: a distinct evidence base — one year on Replied, post #56 · Clinical › Special populations · 21 Jan 2026 · 0 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
Dead volume across syringe and needle combinations Replied, post #52 · Devices › Syringes & needles · 10 Jan 2026 · 0 likes post #51 answers the question as asked. The question underneath it is different. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G)…
-
The headache that turns out to be dehydration Replied, post #131 · Nutrition & Training › Hydration & electrolytes · 9 Jan 2026 · 32 likes On post #127 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Specification in the result column: why that is a meaningful error Replied, post #100 · Analytics › COA interpretation · 5 Jan 2026 · 6 likes This follows post #97 rather than contradicting it. When a document puts the specification in the result column, it has told you the release criterion, not the…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #7 · Pharmacology › Pharmacokinetics · 2 Jan 2026 · 8 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
When a dose reduction is the correct response to a side effect — a second dataset Replied, post #4 · Practice › Dosing & titration · 2 Jan 2026 · 29 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
About the How to Ask category Replied, post #7 · Start Here › How to Ask · 30 Dec 2025 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #39 · Clinical › Bloodwork · 29 Dec 2025 · 0 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
A history of disordered eating: proceeding carefully Replied, post #42 · Wellbeing › Mental health · 28 Dec 2025 · 3 likes This follows post #39 rather than contradicting it. Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #18 · Meta › Site feedback · 12 Dec 2025 · 22 likes Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report it. Site architecture affects usability.
-
Temperature loggers worth the money — the long version Replied, post #84 · Devices › Cold chain · 30 Nov 2025 · 13 likes Worth separating two things that post #80 runs together. Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised powder. Refrigerate…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #56 · Clinical › Special populations · 24 Nov 2025 · 0 likes Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it further. Discussion with a clinician is prudent if this history exists.
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #13 · Start Here › Welcome · 20 Nov 2025 · 0 likes This follows post #10 rather than contradicting it. Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #30 · Analytics › Impurities & related substances · 20 Nov 2025 · 0 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #75 · Compounds › Tirzepatide · 22 Oct 2025 · 4 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
What a confidence interval means, from scratch — the long version Replied, post #8 · Research Methods › Statistics · 18 Oct 2025 · 17 likes P-values and significance: p
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #97 · Lounge › Off topic · 15 Oct 2025 · 1 like Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #2 · Compounds › Oral incretins · 9 Oct 2025 · 4 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #47 · Compounds › Tirzepatide · 30 Sep 2025 · 7 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Reading a supplier's product description as a marketing document Replied, post #65 · Compounds › Other compounds · 2 Sep 2025 · 8 likes post #64 answers the question as asked. The question underneath it is different. How to research a compound with no human data: mechanistic plausibility is one input.…
-
Titles that describe the question, not the situation Replied, post #81 · Start Here › How to Ask · 27 Aug 2025 · 1 like Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #34 · Compounds › Repair & healing peptides · 24 Aug 2025 · 14 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
-
A preprint whose numbers changed substantially at publication Replied, post #22 · Evidence › Preprints · 18 Aug 2025 · 2 likes This follows post #19 rather than contradicting it. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors…
-
How to research a compound with no human data without deceiving yourself Replied, post #68 · Compounds › Other compounds · 2 Aug 2025 · 29 likes I read post #66 twice before replying, because I had assumed the opposite. Reading a supplier's product description as a marketing document: that is exactly what it is.…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #59 · Data & Tools › Calculators · 22 Jul 2025 · 7 likes Picking up post #56: that is the part I would want checked first. Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #26 · Documentation › Doc review · 15 Jul 2025 · 11 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #7 · Analytics › COA interpretation · 14 Jul 2025 · 16 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
A supplier that answers analytical questions with restated claims Replied, post #106 · Sourcing › Red flags · 27 Jun 2025 · 0 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #122 · Compounds › Cagrilintide & amylin analogues · 17 Jun 2025 · 5 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #84 · Compounds › Cagrilintide & amylin analogues · 13 Jun 2025 · 11 likes post #83 answers the question as asked. The question underneath it is different. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but…
-
Interpreting a composition change that is within the error bars Replied, post #3 · Outcomes › Body composition · 12 Jun 2025 · 6 likes post #2 is right about the mechanism and I think understates the practical bit. Comparison to published data: the trials reported mean fat and lean mass changes.…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #65 · Compounds › Tirzepatide · 4 Jun 2025 · 1 like Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
When a tidy document is a signal and when it is decoration Replied, post #4 · Analytics › COA interpretation · 22 May 2025 · 1 like Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Half-life, steady state, and accumulation worked through Replied, post #7 · Pharmacology › Pharmacokinetics · 21 May 2025 · 0 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Pregnancy as an absolute contraindication Replied, post #9 · Safety › Contraindications · 16 May 2025 · 3 likes History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative risk. That is a relative contraindication, not…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #88 · Wellbeing › Mental health · 14 May 2025 · 19 likes When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function, involving a mental health professional is appropriate.…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #74 · Practice › Interactions · 6 May 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reading order for a first week here, and what to skip until later Replied, post #97 · Start Here › Welcome · 23 Apr 2025 · 4 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #102 · Evidence › Journal club · 23 Apr 2025 · 3 likes On post #98 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Adjudicated events and why the definition matters — the long version Replied, post #104 · Evidence › Trials · 17 Apr 2025 · 25 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
Adjudicated events and why the definition matters — the long version Replied, post #91 · Evidence › Trials · 10 Apr 2025 · 1 like post #90 is right about the mechanism and I think understates the practical bit. Surrogate endpoints: an endpoint that is not the outcome that matters but is measured…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #95 · Compounds › Cagrilintide & amylin analogues · 2 Apr 2025 · 27 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #63 · Analytics › COA interpretation · 9 Mar 2025 · 4 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #12 · Compounds › Secretagogues & GH axis · 1 Jan 2025 · 8 likes Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might impair glucose tolerance. The clinical relevance of…
-
Checking someone else's arithmetic: a worked example thread Replied, post #10 · Practice › Reconstitution · 27 Dec 2024 · 19 likes post #9 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #38 · Safety › Adverse events · 22 Dec 2024 · 0 likes Worth separating two things that post #34 runs together. Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious.…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #118 · Practice › Dosing & titration · 4 Dec 2024 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
When "no data" is the complete and final answer Replied, post #19 · Compounds › Other compounds · 11 Nov 2024 · 29 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #16 · Compounds › Other compounds · 8 Nov 2024 · 17 likes I read post #14 twice before replying, because I had assumed the opposite. Research-use-only status is a legal classification, not a safety classification. It means the…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #69 · Compounds › Other compounds · 24 Oct 2024 · 8 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Melanocortin agonists: mechanism and the documented adverse profile Replied, post #7 · Compounds › Other compounds · 8 Oct 2024 · 0 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Progressive overload when the scale is falling — one year on Replied, post #41 · Nutrition & Training › Resistance training · 9 Sep 2024 · 2 likes I read post #39 twice before replying, because I had assumed the opposite. Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #65 · Analytics › COA interpretation · 13 Aug 2024 · 0 likes Coming back to post #63, because the follow-up matters more than the original answer. Purity and content are different measurements: purity tells you what proportion of…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #39 · Compounds › Retatrutide · 18 Jul 2024 · 29 likes post #38 is right about the mechanism and I think understates the practical bit. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple…
-
The mass-error checker and its intended scope Replied, post #50 · Data & Tools › Calculators · 14 Jun 2024 · 0 likes This follows post #47 rather than contradicting it. Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from…